-
Evaluating the Performance of a Supervised Artificial Intelligence Model in Screening Abstracts for Oncology-Focused Targeted Literature Reviews
Sep 9, 2025, 16:22 PM -
Trends in Hospital Treatment of Follicular Lymphoma in Germany
Sep 9, 2025, 16:22 PM -
The Next Frontier in HTA Reviewing the Integration of Artificial Intelligence and Discrete Event Simulation for Resource Modeling
Sep 9, 2025, 16:22 PM -
Burden of Illness and Healthcare Resource Utilization Among Patients Newly Diagnosed With Amyotrophic Lateral Sclerosis in the United States: A Retrospective, Observational, Cohort Design Study
Sep 9, 2025, 16:22 PM -
Economic Modeling in Ophthalmology: Reimagining Cost-Effectiveness Model Structures
Sep 9, 2025, 16:22 PM -
Microcosting Analysis of Oral, Subcutaneous, and Intravenous Second-line Multiple Sclerosis Treatments Administered at Home or in Hospital
Sep 9, 2025, 16:22 PM -
Assessing Treatment Efficiency Indicated in Rare Diseases: Learning From the CEESP Has Economic Opinions
Sep 9, 2025, 16:22 PM -
Framing Matters! Implications of Loss Aversion for Communicating Benefits to Patients in Preference Studies (and Beyond)
Sep 9, 2025, 16:22 PM -
Comparative Safety of B/F/TAF vs. Other Antiretroviral Therapy Regimens for Treatment-Experienced People With HIV-1: A Systematic Literature Review and Indirect Comparisons Using Multilevel Network Meta-Regression
Sep 9, 2025, 16:22 PM -
Clinical and Economic Outcomes of Cannabis-Based Formulations (CBD and CBD/CBG) for Autism Spectrum Disorder (ASD): A HEOR Model Study Analysis
Sep 9, 2025, 16:22 PM -
Enhancing Patient Involvement in European Health Technology Assessment (HTA): From Inconsistent National Practices to Systematic Engagement in Joint Clinical Assessments
Sep 9, 2025, 16:22 PM -
A Matching-Adjusted Indirect Comparison (MAIC) of Rucaparib vs. Niraparib in the Maintenance Treatment of Advanced Ovarian, Fallopian Tube, and Peritoneal Cancer (aOC) After Response to First-Line Platinum-Based Chemotherapy
Sep 9, 2025, 16:22 PM -
Real-World Evidence From Community Oncology: Assessing Secular Trends in Ovarian Cancer Diagnoses From 2014 to 2024
Sep 9, 2025, 16:22 PM -
Using Propensity Weighting Methods With Real-World Data and Noncontrolled Extension Data From a Clinical Trial to Estimate Long-Term Treatment Effect: An Example in Alzheimer’s Disease
Sep 9, 2025, 16:22 PM -
Evaluating the Effectiveness of FitterLife: A Community-Based Virtual Weight Management Program for Overweight Adults Without Diabetes or Hypertension in Singapore
Sep 9, 2025, 16:22 PM -
Market Access Challenges for Oncology Combination Therapies in Europe: A Review of Regulatory Approvals HTA Outcomes and Pricing Dynamics
Sep 9, 2025, 16:22 PM -
Burden of Bloodstream Infections in the United States: Incidence and Healthcare Resource Utilization 2022-2024
Sep 9, 2025, 16:22 PM -
Parental Vaccine Hesitancy in Children With Comorbidities: A Comparative Analysis
Sep 9, 2025, 16:22 PM -
Economic and Epidemiological Burden of Type 1 Diabetes In France
Sep 9, 2025, 16:22 PM -
Development of a New, Adaptable Patient-Reported Outcome Measure of Treatment Satisfaction
Sep 9, 2025, 16:22 PM
